• Discovery of ATG9A and PTOV1 as Novel 14-3-3 Binding Partner

  2026-06-12

  This study uncovers ATG9A and PTOV1 as previously unrecognized 14-3-3 binding proteins, elucidating their distinct regulatory roles in autophagy and cancer progression. The work advances mechanistic understanding of basal autophagy and PTOV1-linked oncogenesis, offering new perspectives for targeted cancer research.

• CHIR-99021 (CT99021): Advancing Chromatin and Cell Fate Cont

  2026-06-11

  This thought-leadership article explores how CHIR-99021 (CT99021) enables precise control of stem cell fate by modulating GSK-3 activity and downstream chromatin accessibility. Integrating recent mechanistic insights and protocol guidance, it bridges the gap between pluripotency, differentiation, and the emerging frontier of single-molecule chromatin structure analysis, providing translational researchers with a strategic roadmap for robust experimental outcomes.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-06-11

  Schwartz’s dissertation introduces a framework to distinguish between drug-induced cell death and proliferative arrest in cancer cells, challenging the conventional reliance on composite viability metrics. This methodological advance enhances the interpretive power of preclinical drug screening, with direct implications for kinase inhibitor studies.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-06-10

  This study reveals that certain kinase inhibitors can simultaneously block kinase activity and accelerate dephosphorylation of p38α MAP kinase by phosphatases. By structurally characterizing these interactions, the research opens new avenues for developing more specific and effective kinase inhibitors for disease modeling and drug discovery.

• Substance P in Applied CNS Research: Protocols and Pitfalls

  2026-06-10

  Substance P is a benchmark tachykinin neuropeptide unlocking advanced pain transmission and immune modulation research. This article details optimized workflows, troubleshooting strategies, and spectral innovations—empowering researchers to maximize data quality and reproducibility using APExBIO's high-purity Substance P.

• (-)-Arctigenin: MEK1 Inhibitor Workflows for Tumor Microenvi

  2026-06-09

  (-)-Arctigenin is a high-purity MEK1 inhibitor with robust anti-inflammatory and antiviral features, making it a standout tool for dissecting tumor microenvironment signaling. This guide translates recent NF-κB axis discoveries into actionable lab protocols and troubleshooting strategies, empowering researchers to model and modulate breast cancer progression with confidence.

• Leupeptin Hemisulfate Salt: Advanced Inhibitor for Precision

  2026-06-09

  Explore how Leupeptin hemisulfate salt enables advanced protease activity regulation, with a deep dive into its molecular action and unique applications in protein degradation and viral replication studies. Gain new insights beyond standard protocols, including direct connections to epigenetic regulation workflows.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-08

  Wang et al. (2024) identify the METTL16-SENP3-LTF axis as a critical mechanism conferring ferroptosis resistance and promoting tumorigenesis in hepatocellular carcinoma (HCC). This discovery reveals new therapeutic targets for sensitizing HCC cells to ferroptotic cell death, with clear implications for cancer research and drug development.

• Inflammation in Ischemic Stroke: Biomarkers and Emerging The

  2026-06-08

  This review synthesizes current knowledge on the inflammatory mechanisms underlying ischemic stroke (IS), emphasizing the dual role of neuroinflammation in both injury and repair. By highlighting the diagnostic and therapeutic value of inflammatory biomarkers and integrating insights from diverse domains, the paper offers a comprehensive resource for advancing IS research and clinical strategy.

• BMS-777607: Redefining c-Met Inhibition for Stem Cell and Ca

  2026-06-07

  Explore the advanced selectivity and unique applications of BMS-777607, a potent c-Met inhibitor, in both cancer metastasis and platelet biomanufacturing via hiPSC protocols. This article offers a deeper analysis and protocol guidance for research teams seeking precision in MET pathway modulation.

• Nitrocefin in β-Lactamase Research: Mechanistic Insight and

  2026-06-06

  This thought-leadership article explores the mechanistic foundation and translational strategy for leveraging Nitrocefin—a chromogenic cephalosporin substrate—in advancing β-lactamase activity measurement, antibiotic resistance profiling, and inhibitor discovery. Integrating recent in silico screening breakthroughs and actionable workflow guidance, we provide a roadmap for researchers to elevate experimental rigor and clinical relevance in combating antibiotic resistance.

• Renal Blood Flow Impacts of Norepinephrine in Septic Rat Mod

  2026-06-05

  This study investigates how norepinephrine and phenylephrine administration, in combination with specific K+ channel blockers, affects renal blood flow in septic rats. The findings highlight complex interactions between adrenergic receptor signaling and potassium channel function, providing new insight into kidney perfusion during sepsis and informing the design of preclinical cardiomyopathy research models.

• THBS1 as a Prognostic Biomarker and Lipid Regulator in Laryn

  2026-06-05

  A recent integrative analysis identified THBS1 as a central prognostic biomarker with therapeutic potential in laryngeal cancer. The study employs multi-omics bioinformatics and in vitro experiments to reveal THBS1’s dual roles in immune suppression and altered lipid metabolism, providing new avenues for biomarker-driven research and targeted therapies.

• Neuroinflammation and the CGRP/SP-Piezo2 Axis in Trigeminal

  2026-06-04

  Liao et al. reveal a mechanistic link between chronic trigeminal nerve root compression and mechanical allodynia, identifying a Ca2+-driven neuroinflammatory feedback loop involving CGRP, substance P, and Piezo2. These insights refine the understanding of trigeminal neuralgia pathogenesis and highlight novel intervention points for neuroinflammatory pain.

• 5-Azacytidine in Epigenetic Workflows: Demethylation & Cance

  2026-06-04

  Leverage 5-Azacytidine for precision DNA demethylation, gene reactivation, and robust cancer modeling. This guide translates cutting-edge research into actionable protocols, troubleshooting insights, and workflow innovations that maximize APExBIO’s reagent performance.

438 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page